(Q46484712)
Statements
1 reference
Role of KRAS and EGFR as biomarkers of response to erlotinib in National Cancer Institute of Canada Clinical Trials Group Study BR.21. (English)
1 reference
1 reference
1 reference
Chang-Qi Zhu
1 reference
Keyue Ding
1 reference
Akira Sakurada
1 reference
Jean-Claude Cutz
1 reference
Ni Liu
1 reference
Tong Zhang
1 reference
Paula Marrano
1 reference
Marlo Whitehead
1 reference
Lesley Seymour
1 reference
Frances A Shepherd
1 reference
National Cancer Institute of Canada Clinical Trials Group Study BR.21
1 reference
14 July 2008
1 reference
26
1 reference
26
1 reference
4268-4275
1 reference